Joseph W. LaPlume, EVP, Corporate Strategy & Develop at CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL), sold 790 shares at $292.75 ($231K) on 2022-02-23, disclosed to the SEC on 2022-02-24.
Seasonal sale ($231k) by EVP, Corporate Strategy & Develop — this insider has traded CRL in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $292.75 | 395 | $116K | 50.0% |
| 2 | $292.75 | 395 | $116K | 50.0% |
| Total | $292.75 avg | 790 | $231K | 100% |
| Filing → |
| CRL | SELL | 2025-08-20 | $126K | — | Filing → |
| CRL | SELL | 2025-08-08 | $60K | — | Filing → |
| CRL | SELL | 2025-05-15 | $73K | — | Filing → |